The complexities of diagnosing young-onset Alzheimer’s dementia and the need for swift identification
YOAD remains underrecognized and diagnostically challenging, limiting timely access to targeted therapies and the integration of multimodal biomarkers and genetic testing is essential for early diagnosis, as is the need for a comprehensive neuropsychological assessment to capture atypical phenotypes.